Alan Wise (L) and Peter Trill (Duke Street Bio)
They sold their last biotech to Merck. Now they're back with a PARP outfit named after a London street
In 2016, Peter Trill and Alan Wise sold IOmet Pharma (an I/O outfit as the name suggests) to Merck for $400 million.
Now, some six …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
